Michael Trettel
Examiner (ID: 14974)
Most Active Art Unit | 3673 |
Art Unit(s) | 3505, 3633, 3508, 3673, 3627, 3628 |
Total Applications | 3400 |
Issued Applications | 2895 |
Pending Applications | 103 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10686254
[patent_doc_number] => 20160032400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'METHOD FOR THE PROGNOSIS AND TREATMENT OF CANCER METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 14/776412
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 32491
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776412
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776412 | METHOD FOR THE PROGNOSIS AND TREATMENT OF CANCER METASTASIS | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10954550
[patent_doc_number] => 20140357573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 14/210124
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13359
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210124
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/210124 | PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA | Mar 12, 2014 | Abandoned |
Array
(
[id] => 9793240
[patent_doc_number] => 20150005184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'DIAGNOSIS OF MELANOMA BY NUCLEIC ACID ANALYSIS'
[patent_app_type] => utility
[patent_app_number] => 14/208155
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 30032
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14208155
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/208155 | DIAGNOSIS OF MELANOMA BY NUCLEIC ACID ANALYSIS | Mar 12, 2014 | Abandoned |
Array
(
[id] => 10678437
[patent_doc_number] => 20160024583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHODS FOR EVALUATING COPD STATUS'
[patent_app_type] => utility
[patent_app_number] => 14/775379
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12063
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775379
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775379 | Methods for evaluating COPD status | Mar 12, 2014 | Issued |
Array
(
[id] => 10678441
[patent_doc_number] => 20160024587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'MARKERS ASSOCIATED WITH WNT INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/774212
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18004
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774212
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/774212 | Markers associated with Wnt inhibitors | Mar 9, 2014 | Issued |
Array
(
[id] => 9686566
[patent_doc_number] => 20140243332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'METHODS OF TREATING CANCERS CHARACTERIZED BY ABERRENT ROS1 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/190246
[patent_app_country] => US
[patent_app_date] => 2014-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15143
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14190246
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/190246 | METHODS OF TREATING CANCERS CHARACTERIZED BY ABERRENT ROS1 ACTIVITY | Feb 25, 2014 | Abandoned |
Array
(
[id] => 9771104
[patent_doc_number] => 20140294768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'RESPONSIVENESS TO ANGIOGENESIS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/191040
[patent_app_country] => US
[patent_app_date] => 2014-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19371
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14191040
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/191040 | RESPONSIVENESS TO ANGIOGENESIS INHIBITORS | Feb 25, 2014 | Abandoned |
Array
(
[id] => 9643259
[patent_doc_number] => 20140221372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'METHOD OF ADMINISTRATION AND TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/173973
[patent_app_country] => US
[patent_app_date] => 2014-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18880
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14173973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/173973 | METHOD OF ADMINISTRATION AND TREATMENT | Feb 5, 2014 | Abandoned |
Array
(
[id] => 9603014
[patent_doc_number] => 20140199697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'QUANTIFICATION AND MOLECULAR DETECTION OF LACTIC ACID BACTERIA IN A SAMPLE'
[patent_app_type] => utility
[patent_app_number] => 14/154824
[patent_app_country] => US
[patent_app_date] => 2014-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5813
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14154824
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/154824 | QUANTIFICATION AND MOLECULAR DETECTION OF LACTIC ACID BACTERIA IN A SAMPLE | Jan 13, 2014 | Abandoned |
Array
(
[id] => 9656689
[patent_doc_number] => 20140227693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND STROKE'
[patent_app_type] => utility
[patent_app_number] => 14/153926
[patent_app_country] => US
[patent_app_date] => 2014-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 56247
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14153926
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/153926 | GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND STROKE | Jan 12, 2014 | Abandoned |
Array
(
[id] => 9464006
[patent_doc_number] => 20140128433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'METHODS FOR THE ADMINISTRATION OF ILOPERIDONE'
[patent_app_type] => utility
[patent_app_number] => 14/150575
[patent_app_country] => US
[patent_app_date] => 2014-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6710
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14150575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/150575 | Methods for the administration of iloperidone | Jan 7, 2014 | Issued |
Array
(
[id] => 9616858
[patent_doc_number] => 20140206716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 14/150223
[patent_app_country] => US
[patent_app_date] => 2014-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 26707
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14150223
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/150223 | METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE | Jan 7, 2014 | Abandoned |
Array
(
[id] => 9435386
[patent_doc_number] => 20140113293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'METHOD FOR THE DETECTION OF EGFR MUTATIONS IN BLOOD SAMPLES'
[patent_app_type] => utility
[patent_app_number] => 14/138013
[patent_app_country] => US
[patent_app_date] => 2013-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5351
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/138013 | METHOD FOR THE DETECTION OF EGFR MUTATIONS IN BLOOD SAMPLES | Dec 20, 2013 | Abandoned |
Array
(
[id] => 10430632
[patent_doc_number] => 20150315643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'BLOOD TRANSCRIPTIONAL SIGNATURES OF ACTIVE PULMONARY TUBERCULOSIS AND SARCOIDOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/651989
[patent_app_country] => US
[patent_app_date] => 2013-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 29176
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14651989
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/651989 | BLOOD TRANSCRIPTIONAL SIGNATURES OF ACTIVE PULMONARY TUBERCULOSIS AND SARCOIDOSIS | Dec 12, 2013 | Abandoned |
Array
(
[id] => 11092776
[patent_doc_number] => 20160289745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'NUCLEIC ACID ASSAY FOR DIAGNOSING OR MONITORING A PATHOGEN INFECTION IN A BODILY FLUID FROM A SUBJECT TREATED WITH AN ANTI-PATHOGENIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/442718
[patent_app_country] => US
[patent_app_date] => 2013-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19256
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442718
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442718 | NUCLEIC ACID ASSAY FOR DIAGNOSING OR MONITORING A PATHOGEN INFECTION IN A BODILY FLUID FROM A SUBJECT TREATED WITH AN ANTI-PATHOGENIC AGENT | Nov 17, 2013 | Abandoned |
Array
(
[id] => 9307219
[patent_doc_number] => 20140045893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'METHODS FOR THE ADMINISTRATION OF ILOPERIDONE'
[patent_app_type] => utility
[patent_app_number] => 14/060978
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6671
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14060978
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/060978 | METHODS FOR THE ADMINISTRATION OF ILOPERIDONE | Oct 22, 2013 | Abandoned |
Array
(
[id] => 9383901
[patent_doc_number] => 20140087383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'NUCLEIC ACID PROBES AND METHODS FOR DETECTING PLASMODIUM PARASITES'
[patent_app_type] => utility
[patent_app_number] => 14/060215
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5491
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14060215
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/060215 | NUCLEIC ACID PROBES AND METHODS FOR DETECTING PLASMODIUM PARASITES | Oct 21, 2013 | Abandoned |
Array
(
[id] => 16476485
[patent_doc_number] => 10851414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Methods for determining carrier status
[patent_app_type] => utility
[patent_app_number] => 14/057673
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12003
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057673
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/057673 | Methods for determining carrier status | Oct 17, 2013 | Issued |
Array
(
[id] => 11773748
[patent_doc_number] => 09382592
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Primers and probes for detection and discrimination of types and subtypes of influenza viruses'
[patent_app_type] => utility
[patent_app_number] => 14/056810
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 70
[patent_figures_cnt] => 75
[patent_no_of_words] => 23851
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14056810
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/056810 | Primers and probes for detection and discrimination of types and subtypes of influenza viruses | Oct 16, 2013 | Issued |
Array
(
[id] => 9421686
[patent_doc_number] => 20140106337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'METHODS, NUCLEIC ACIDS, AND KITS FOR DETECTION OF PARVOVIRUS B19'
[patent_app_type] => utility
[patent_app_number] => 14/053245
[patent_app_country] => US
[patent_app_date] => 2013-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 17983
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053245
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053245 | Methods for detection of parvovirus B19 | Oct 13, 2013 | Issued |